Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Mar-24 6:04 AM View:  | Dyne Therapeutics, Inc. (DYN) | 11-Mar-24 | Sale (Planned) | 2,292 | $25.70 | $58,904.40 | (1%) 159.09K to 156.8K | |
| 13-Mar-24 6:04 AM View: | Dyne Therapeutics, Inc. (DYN) | 08-Mar-24 | Private Sale | 27,199 | $26.67 | $725,344.00 | (15%) 186.29K to 159.09K | |
| 11-Mar-24 9:56 PM View: | Dyne Therapeutics, Inc. (DYN) | 07-Mar-24 | Private Sale (Planned) | 1,591 | $25.85 | $41,127.40 | (< 1%) 187.88K to 186.29K | |
| 12-Dec-23 5:34 PM View: | Dyne Therapeutics, Inc. (DYN) | 11-Dec-23 | Market Sale (Planned) | 1,616 | $10.72 | $17,323.50 | (< 1%) 189.5K to 187.88K | (1%) |
| 16-Nov-23 4:30 PM View: | Dyne Therapeutics, Inc. (DYN) | 15-Nov-23 | Grant | 94,893 | -- | -- | 100% 94.61K to 189.5K | |
| 02-Nov-23 5:16 PM View: | Dyne Therapeutics, Inc. (DYN) | 02-Nov-23 | Sale (Planned) | 9,939 | $7.40 | $73,548.60 | (10%) 104.54K to 94.61K | |
| 20-Sep-23 4:48 PM View: | Dyne Therapeutics, Inc. (DYN) | 18-Sep-23 | Market Sale (Planned) | 2,672 | $9.41 | $25,143.50 | (2%) 107.22K to 104.54K | (15%) |
| 13-Sep-23 7:51 PM View: | Dyne Therapeutics, Inc. (DYN) | 12-Sep-23 | Market Sale (Planned) | 1,635 | $10.41 | $17,020.30 | (2%) 108.85K to 107.22K | (4%) |
| 14-Jun-23 6:40 PM View: | Dyne Therapeutics, Inc. (DYN) | 13-Jun-23 | Private Sale (Planned) | 1,625 | $12.43 | $20,198.80 | (1%) 110.48K to 108.85K | |
| 15-Mar-23 5:50 PM View: | Dyne Therapeutics, Inc. (DYN) | 14-Mar-23 | Private Sale (Planned) | 1,559 | $13.33 | $20,781.50 | (1%) 112.03K to 110.48K | |
| 13-Dec-22 5:05 PM View: | Dyne Therapeutics, Inc. (DYN) | 12-Dec-22 | Sale (Planned) | 751 | $10.87 | $8,163.37 | (< 1%) 112.79K to 112.03K | |
| 13-Dec-22 5:05 PM View: | Dyne Therapeutics, Inc. (DYN) | 09-Dec-22 | Grant | 44,000 | -- | -- | 64% 68.79K to 112.79K | |
| 21-Sep-22 4:08 PM View: | Dyne Therapeutics, Inc. (DYN) | 20-Sep-22 | Disposition | 2,629 | $13.70 | $36,017.30 | (4%) 71.42K to 68.79K | |
| 15-Sep-22 5:26 PM View: | Dyne Therapeutics, Inc. (DYN) | 15-Sep-22 | Disposition | 786 | $14.05 | $11,043.30 | (1%) 72.2K to 71.42K | |
| 15-Jun-22 8:03 PM View: | Dyne Therapeutics, Inc. (DYN) | 14-Jun-22 | Disposition | 802 | $4.95 | $3,969.90 | (1%) 73.0K to 72.2K | |
| 14-Mar-22 5:08 PM View: | Dyne Therapeutics, Inc. (DYN) | 11-Mar-22 | Sale (Planned) | 765 | $8.73 | $6,678.45 | (1%) 73.77K to 73.0K | |
| 14-Dec-21 4:21 PM View: | Dyne Therapeutics, Inc. (DYN) | 10-Dec-21 | Grant | 40,315 | -- | -- | 121% 33.45K to 73.77K | |
| 24-Sep-21 10:00 PM View: | Dyne Therapeutics, Inc. (DYN) | 23-Sep-21 | Market Sale (Planned) | 2,451 | $17.22 | $42,206.20 | (7%) 35.9K to 33.45K | 5% |
| 18-Sep-20 5:16 PM View: | Dyne Therapeutics, Inc. (DYN) | 17-Sep-20 | Grant | 35,904 | -- | -- | 100% 0 to 35.9K | |
| 10-Dec-18 4:11 PM View: | Bluebird Bio, Inc. (BLUE) | 06-Dec-18 | Market Sale (Planned) | 1,875 | $105.71 | $198,198.00 | (12%) 15.61K to 13.73K | 57% |
| 06-Dec-18 4:14 PM View: | Bluebird Bio, Inc. (BLUE) | 03-Dec-18 | Market Sale | 1,890 | $113.83 | $215,135.00 | (11%) 17.5K to 15.61K | 60% |
| 06-Jun-18 4:36 PM View: | Bluebird Bio, Inc. (BLUE) | 04-Jun-18 | Option Exercise | 3,500 | $68.65 | $240,275.00 | 20% 17.5K to 21.0K | |
| 06-Jun-18 4:36 PM View: | Bluebird Bio, Inc. (BLUE) | 04-Jun-18 | Market Option Sale (Planned) | 3,500 | $199.11 | $696,892.00 | (17%) 21.0K to 17.5K | 77% |
| 02-Mar-18 4:01 PM View: | Bluebird Bio, Inc. (BLUE) | 28-Feb-18 | Option Exercise | 1,044 | $68.65 | $71,670.60 | 6% 17.5K to 18.54K | |
| 02-Mar-18 4:01 PM View: | Bluebird Bio, Inc. (BLUE) | 28-Feb-18 | Market Option Sale (Planned) | 1,044 | $202.67 | $211,592.00 | (6%) 18.54K to 17.5K | 77% |
| 05-Feb-18 4:04 PM View: | Bluebird Bio, Inc. (BLUE) | 01-Feb-18 | Grant | 6,250 | -- | -- | 56% 11.25K to 17.5K | |
| 01-Feb-18 4:31 PM View: | Bluebird Bio, Inc. (BLUE) | 30-Jan-18 | Option Exercise | 14,794 | $68.65 | $1,015,610.00 | 108% 13.72K to 28.51K | |
| 01-Feb-18 4:31 PM View: | Bluebird Bio, Inc. (BLUE) | 30-Jan-18 | Market Option Sale (Planned) | 14,794 | $195.91 | $2,898,290.00 | (52%) 28.51K to 13.72K | 77% |
| 01-Feb-18 4:31 PM View: | Bluebird Bio, Inc. (BLUE) | 30-Jan-18 | Market Sale (Planned) | 2,468 | $195.91 | $483,505.00 | (18%) 13.72K to 11.25K | 77% |
| 05-Dec-17 4:09 PM View: | Bluebird Bio, Inc. (BLUE) | 01-Dec-17 | Market Sale | 1,282 | $172.15 | $220,696.00 | (9%) 15.0K to 13.72K | 73% |
| 02-Dec-16 4:08 PM View: | Bluebird Bio, Inc. (BLUE) | 01-Dec-16 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K |